ArticleNeoplasia (New York, N.Y.)2020

Liver X Receptor Agonism Sensitizes a Subset of Hepatocellular Carcinoma to Sorafenib by Dual-Inhibiting MET and EGFR.

Weiqing Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.